Medical Care
Global Anti-fungal Drugs Market Research Report 2025
- Sep 18, 25
- ID: 507551
- Pages: 85
- Figures: 85
- Views: 7
This report aims to provide a comprehensive presentation of the global market for Anti-fungal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-fungal Drugs.
The Anti-fungal Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-fungal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-fungal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals
Segment by Type
Powder
Ointment
Tablet
Other
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-fungal Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Anti-fungal Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-fungal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-fungal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals
Segment by Type
Powder
Ointment
Tablet
Other
Segment by Application
Hospital
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-fungal Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-fungal Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Powder
1.2.3 Ointment
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anti-fungal Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-fungal Drugs Market Perspective (2020-2031)
2.2 Global Anti-fungal Drugs Growth Trends by Region
2.2.1 Global Anti-fungal Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-fungal Drugs Historic Market Size by Region (2020-2025)
2.2.3 Anti-fungal Drugs Forecasted Market Size by Region (2026-2031)
2.3 Anti-fungal Drugs Market Dynamics
2.3.1 Anti-fungal Drugs Industry Trends
2.3.2 Anti-fungal Drugs Market Drivers
2.3.3 Anti-fungal Drugs Market Challenges
2.3.4 Anti-fungal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-fungal Drugs Players by Revenue
3.1.1 Global Top Anti-fungal Drugs Players by Revenue (2020-2025)
3.1.2 Global Anti-fungal Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Anti-fungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-fungal Drugs Revenue
3.4 Global Anti-fungal Drugs Market Concentration Ratio
3.4.1 Global Anti-fungal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-fungal Drugs Revenue in 2024
3.5 Global Key Players of Anti-fungal Drugs Head office and Area Served
3.6 Global Key Players of Anti-fungal Drugs, Product and Application
3.7 Global Key Players of Anti-fungal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-fungal Drugs Breakdown Data by Type
4.1 Global Anti-fungal Drugs Historic Market Size by Type (2020-2025)
4.2 Global Anti-fungal Drugs Forecasted Market Size by Type (2026-2031)
5 Anti-fungal Drugs Breakdown Data by Application
5.1 Global Anti-fungal Drugs Historic Market Size by Application (2020-2025)
5.2 Global Anti-fungal Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-fungal Drugs Market Size (2020-2031)
6.2 North America Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-fungal Drugs Market Size by Country (2020-2025)
6.4 North America Anti-fungal Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-fungal Drugs Market Size (2020-2031)
7.2 Europe Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-fungal Drugs Market Size by Country (2020-2025)
7.4 Europe Anti-fungal Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-fungal Drugs Market Size (2020-2031)
8.2 Asia-Pacific Anti-fungal Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-fungal Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-fungal Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-fungal Drugs Market Size (2020-2031)
9.2 Latin America Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-fungal Drugs Market Size by Country (2020-2025)
9.4 Latin America Anti-fungal Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-fungal Drugs Market Size (2020-2031)
10.2 Middle East & Africa Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-fungal Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-fungal Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-fungal Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Anti-fungal Drugs Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Anti-fungal Drugs Introduction
11.2.4 Astellas Pharma Revenue in Anti-fungal Drugs Business (2020-2025)
11.2.5 Astellas Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Anti-fungal Drugs Introduction
11.3.4 Bayer Revenue in Anti-fungal Drugs Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anti-fungal Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Glenmark
11.5.1 Glenmark Company Details
11.5.2 Glenmark Business Overview
11.5.3 Glenmark Anti-fungal Drugs Introduction
11.5.4 Glenmark Revenue in Anti-fungal Drugs Business (2020-2025)
11.5.5 Glenmark Recent Development
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Details
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Anti-fungal Drugs Introduction
11.6.4 Kramer Laboratories Revenue in Anti-fungal Drugs Business (2020-2025)
11.6.5 Kramer Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Anti-fungal Drugs Introduction
11.7.4 Merck Revenue in Anti-fungal Drugs Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Anti-fungal Drugs Introduction
11.8.4 Novartis Revenue in Anti-fungal Drugs Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-fungal Drugs Introduction
11.9.4 Pfizer Revenue in Anti-fungal Drugs Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 SCYNEXIS
11.10.1 SCYNEXIS Company Details
11.10.2 SCYNEXIS Business Overview
11.10.3 SCYNEXIS Anti-fungal Drugs Introduction
11.10.4 SCYNEXIS Revenue in Anti-fungal Drugs Business (2020-2025)
11.10.5 SCYNEXIS Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Anti-fungal Drugs Introduction
11.11.4 Sanofi Revenue in Anti-fungal Drugs Business (2020-2025)
11.11.5 Sanofi Recent Development
11.12 Gilead Science
11.12.1 Gilead Science Company Details
11.12.2 Gilead Science Business Overview
11.12.3 Gilead Science Anti-fungal Drugs Introduction
11.12.4 Gilead Science Revenue in Anti-fungal Drugs Business (2020-2025)
11.12.5 Gilead Science Recent Development
11.13 Enzon Pharmaceuticals
11.13.1 Enzon Pharmaceuticals Company Details
11.13.2 Enzon Pharmaceuticals Business Overview
11.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Introduction
11.13.4 Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2020-2025)
11.13.5 Enzon Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-fungal Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Powder
1.2.3 Ointment
1.2.4 Tablet
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anti-fungal Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-fungal Drugs Market Perspective (2020-2031)
2.2 Global Anti-fungal Drugs Growth Trends by Region
2.2.1 Global Anti-fungal Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-fungal Drugs Historic Market Size by Region (2020-2025)
2.2.3 Anti-fungal Drugs Forecasted Market Size by Region (2026-2031)
2.3 Anti-fungal Drugs Market Dynamics
2.3.1 Anti-fungal Drugs Industry Trends
2.3.2 Anti-fungal Drugs Market Drivers
2.3.3 Anti-fungal Drugs Market Challenges
2.3.4 Anti-fungal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-fungal Drugs Players by Revenue
3.1.1 Global Top Anti-fungal Drugs Players by Revenue (2020-2025)
3.1.2 Global Anti-fungal Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Anti-fungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-fungal Drugs Revenue
3.4 Global Anti-fungal Drugs Market Concentration Ratio
3.4.1 Global Anti-fungal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-fungal Drugs Revenue in 2024
3.5 Global Key Players of Anti-fungal Drugs Head office and Area Served
3.6 Global Key Players of Anti-fungal Drugs, Product and Application
3.7 Global Key Players of Anti-fungal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-fungal Drugs Breakdown Data by Type
4.1 Global Anti-fungal Drugs Historic Market Size by Type (2020-2025)
4.2 Global Anti-fungal Drugs Forecasted Market Size by Type (2026-2031)
5 Anti-fungal Drugs Breakdown Data by Application
5.1 Global Anti-fungal Drugs Historic Market Size by Application (2020-2025)
5.2 Global Anti-fungal Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-fungal Drugs Market Size (2020-2031)
6.2 North America Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-fungal Drugs Market Size by Country (2020-2025)
6.4 North America Anti-fungal Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-fungal Drugs Market Size (2020-2031)
7.2 Europe Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-fungal Drugs Market Size by Country (2020-2025)
7.4 Europe Anti-fungal Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-fungal Drugs Market Size (2020-2031)
8.2 Asia-Pacific Anti-fungal Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-fungal Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-fungal Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-fungal Drugs Market Size (2020-2031)
9.2 Latin America Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-fungal Drugs Market Size by Country (2020-2025)
9.4 Latin America Anti-fungal Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-fungal Drugs Market Size (2020-2031)
10.2 Middle East & Africa Anti-fungal Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-fungal Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-fungal Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-fungal Drugs Introduction
11.1.4 Abbott Laboratories Revenue in Anti-fungal Drugs Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Anti-fungal Drugs Introduction
11.2.4 Astellas Pharma Revenue in Anti-fungal Drugs Business (2020-2025)
11.2.5 Astellas Pharma Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Anti-fungal Drugs Introduction
11.3.4 Bayer Revenue in Anti-fungal Drugs Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anti-fungal Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Glenmark
11.5.1 Glenmark Company Details
11.5.2 Glenmark Business Overview
11.5.3 Glenmark Anti-fungal Drugs Introduction
11.5.4 Glenmark Revenue in Anti-fungal Drugs Business (2020-2025)
11.5.5 Glenmark Recent Development
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Details
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Anti-fungal Drugs Introduction
11.6.4 Kramer Laboratories Revenue in Anti-fungal Drugs Business (2020-2025)
11.6.5 Kramer Laboratories Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Anti-fungal Drugs Introduction
11.7.4 Merck Revenue in Anti-fungal Drugs Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Anti-fungal Drugs Introduction
11.8.4 Novartis Revenue in Anti-fungal Drugs Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Anti-fungal Drugs Introduction
11.9.4 Pfizer Revenue in Anti-fungal Drugs Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 SCYNEXIS
11.10.1 SCYNEXIS Company Details
11.10.2 SCYNEXIS Business Overview
11.10.3 SCYNEXIS Anti-fungal Drugs Introduction
11.10.4 SCYNEXIS Revenue in Anti-fungal Drugs Business (2020-2025)
11.10.5 SCYNEXIS Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Anti-fungal Drugs Introduction
11.11.4 Sanofi Revenue in Anti-fungal Drugs Business (2020-2025)
11.11.5 Sanofi Recent Development
11.12 Gilead Science
11.12.1 Gilead Science Company Details
11.12.2 Gilead Science Business Overview
11.12.3 Gilead Science Anti-fungal Drugs Introduction
11.12.4 Gilead Science Revenue in Anti-fungal Drugs Business (2020-2025)
11.12.5 Gilead Science Recent Development
11.13 Enzon Pharmaceuticals
11.13.1 Enzon Pharmaceuticals Company Details
11.13.2 Enzon Pharmaceuticals Business Overview
11.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Introduction
11.13.4 Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2020-2025)
11.13.5 Enzon Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-fungal Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Powder
Table 3. Key Players of Ointment
Table 4. Key Players of Tablet
Table 5. Key Players of Other
Table 6. Global Anti-fungal Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Anti-fungal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anti-fungal Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Anti-fungal Drugs Market Share by Region (2020-2025)
Table 10. Global Anti-fungal Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Anti-fungal Drugs Market Share by Region (2026-2031)
Table 12. Anti-fungal Drugs Market Trends
Table 13. Anti-fungal Drugs Market Drivers
Table 14. Anti-fungal Drugs Market Challenges
Table 15. Anti-fungal Drugs Market Restraints
Table 16. Global Anti-fungal Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Anti-fungal Drugs Market Share by Players (2020-2025)
Table 18. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2024)
Table 19. Ranking of Global Top Anti-fungal Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Anti-fungal Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Anti-fungal Drugs, Headquarters and Area Served
Table 22. Global Key Players of Anti-fungal Drugs, Product and Application
Table 23. Global Key Players of Anti-fungal Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-fungal Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Anti-fungal Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Anti-fungal Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Anti-fungal Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Anti-fungal Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Anti-fungal Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Anti-fungal Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Anti-fungal Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Anti-fungal Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Anti-fungal Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Anti-fungal Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Anti-fungal Drugs Product
Table 51. Abbott Laboratories Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Astellas Pharma Company Details
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Anti-fungal Drugs Product
Table 56. Astellas Pharma Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. Bayer Company Details
Table 59. Bayer Business Overview
Table 60. Bayer Anti-fungal Drugs Product
Table 61. Bayer Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 62. Bayer Recent Development
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Anti-fungal Drugs Product
Table 66. GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Glenmark Company Details
Table 69. Glenmark Business Overview
Table 70. Glenmark Anti-fungal Drugs Product
Table 71. Glenmark Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 72. Glenmark Recent Development
Table 73. Kramer Laboratories Company Details
Table 74. Kramer Laboratories Business Overview
Table 75. Kramer Laboratories Anti-fungal Drugs Product
Table 76. Kramer Laboratories Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 77. Kramer Laboratories Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Anti-fungal Drugs Product
Table 81. Merck Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Anti-fungal Drugs Product
Table 86. Novartis Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Anti-fungal Drugs Product
Table 91. Pfizer Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. SCYNEXIS Company Details
Table 94. SCYNEXIS Business Overview
Table 95. SCYNEXIS Anti-fungal Drugs Product
Table 96. SCYNEXIS Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 97. SCYNEXIS Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Anti-fungal Drugs Product
Table 101. Sanofi Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Gilead Science Company Details
Table 104. Gilead Science Business Overview
Table 105. Gilead Science Anti-fungal Drugs Product
Table 106. Gilead Science Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 107. Gilead Science Recent Development
Table 108. Enzon Pharmaceuticals Company Details
Table 109. Enzon Pharmaceuticals Business Overview
Table 110. Enzon Pharmaceuticals Anti-fungal Drugs Product
Table 111. Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 112. Enzon Pharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Anti-fungal Drugs Picture
Figure 2. Global Anti-fungal Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-fungal Drugs Market Share by Type: 2024 VS 2031
Figure 4. Powder Features
Figure 5. Ointment Features
Figure 6. Tablet Features
Figure 7. Other Features
Figure 8. Global Anti-fungal Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-fungal Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Online Pharmacy Case Studies
Figure 13. Anti-fungal Drugs Report Years Considered
Figure 14. Global Anti-fungal Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Anti-fungal Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Anti-fungal Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Anti-fungal Drugs Market Share by Players in 2024
Figure 18. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Anti-fungal Drugs Revenue in 2024
Figure 20. North America Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 22. United States Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 26. Germany Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Anti-fungal Drugs Market Share by Region (2020-2031)
Figure 34. China Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 50. Astellas Pharma Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 53. Glenmark Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 54. Kramer Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 58. SCYNEXIS Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 60. Gilead Science Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 61. Enzon Pharmaceuticals Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Anti-fungal Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Powder
Table 3. Key Players of Ointment
Table 4. Key Players of Tablet
Table 5. Key Players of Other
Table 6. Global Anti-fungal Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Anti-fungal Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anti-fungal Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Anti-fungal Drugs Market Share by Region (2020-2025)
Table 10. Global Anti-fungal Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Anti-fungal Drugs Market Share by Region (2026-2031)
Table 12. Anti-fungal Drugs Market Trends
Table 13. Anti-fungal Drugs Market Drivers
Table 14. Anti-fungal Drugs Market Challenges
Table 15. Anti-fungal Drugs Market Restraints
Table 16. Global Anti-fungal Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Anti-fungal Drugs Market Share by Players (2020-2025)
Table 18. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2024)
Table 19. Ranking of Global Top Anti-fungal Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Anti-fungal Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Anti-fungal Drugs, Headquarters and Area Served
Table 22. Global Key Players of Anti-fungal Drugs, Product and Application
Table 23. Global Key Players of Anti-fungal Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-fungal Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Anti-fungal Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Anti-fungal Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Anti-fungal Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Anti-fungal Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Anti-fungal Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Anti-fungal Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Anti-fungal Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Anti-fungal Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Anti-fungal Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Anti-fungal Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Anti-fungal Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Anti-fungal Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Anti-fungal Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Laboratories Company Details
Table 49. Abbott Laboratories Business Overview
Table 50. Abbott Laboratories Anti-fungal Drugs Product
Table 51. Abbott Laboratories Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 52. Abbott Laboratories Recent Development
Table 53. Astellas Pharma Company Details
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Anti-fungal Drugs Product
Table 56. Astellas Pharma Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. Bayer Company Details
Table 59. Bayer Business Overview
Table 60. Bayer Anti-fungal Drugs Product
Table 61. Bayer Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 62. Bayer Recent Development
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Anti-fungal Drugs Product
Table 66. GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Glenmark Company Details
Table 69. Glenmark Business Overview
Table 70. Glenmark Anti-fungal Drugs Product
Table 71. Glenmark Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 72. Glenmark Recent Development
Table 73. Kramer Laboratories Company Details
Table 74. Kramer Laboratories Business Overview
Table 75. Kramer Laboratories Anti-fungal Drugs Product
Table 76. Kramer Laboratories Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 77. Kramer Laboratories Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Anti-fungal Drugs Product
Table 81. Merck Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 82. Merck Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Anti-fungal Drugs Product
Table 86. Novartis Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Anti-fungal Drugs Product
Table 91. Pfizer Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. SCYNEXIS Company Details
Table 94. SCYNEXIS Business Overview
Table 95. SCYNEXIS Anti-fungal Drugs Product
Table 96. SCYNEXIS Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 97. SCYNEXIS Recent Development
Table 98. Sanofi Company Details
Table 99. Sanofi Business Overview
Table 100. Sanofi Anti-fungal Drugs Product
Table 101. Sanofi Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 102. Sanofi Recent Development
Table 103. Gilead Science Company Details
Table 104. Gilead Science Business Overview
Table 105. Gilead Science Anti-fungal Drugs Product
Table 106. Gilead Science Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 107. Gilead Science Recent Development
Table 108. Enzon Pharmaceuticals Company Details
Table 109. Enzon Pharmaceuticals Business Overview
Table 110. Enzon Pharmaceuticals Anti-fungal Drugs Product
Table 111. Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2020-2025) & (US$ Million)
Table 112. Enzon Pharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Anti-fungal Drugs Picture
Figure 2. Global Anti-fungal Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-fungal Drugs Market Share by Type: 2024 VS 2031
Figure 4. Powder Features
Figure 5. Ointment Features
Figure 6. Tablet Features
Figure 7. Other Features
Figure 8. Global Anti-fungal Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-fungal Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Online Pharmacy Case Studies
Figure 13. Anti-fungal Drugs Report Years Considered
Figure 14. Global Anti-fungal Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Anti-fungal Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Anti-fungal Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Anti-fungal Drugs Market Share by Players in 2024
Figure 18. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Anti-fungal Drugs Revenue in 2024
Figure 20. North America Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 22. United States Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 26. Germany Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Anti-fungal Drugs Market Share by Region (2020-2031)
Figure 34. China Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Anti-fungal Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Anti-fungal Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 50. Astellas Pharma Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 51. Bayer Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 53. Glenmark Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 54. Kramer Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 58. SCYNEXIS Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 60. Gilead Science Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 61. Enzon Pharmaceuticals Revenue Growth Rate in Anti-fungal Drugs Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232